On June 4, 2010
AstraZeneca Learns the FDA May Have Gotten Wise to Copy-Cat Drugs
Could it be that the FDA is throwing up some roadblocks against the ever-popular pharmaceutical company business strategy of taking a drug that is about to go off-patent, tweaking it a bit, and selling it as a new product with
…
0 Comments